Search results
26 Jun 2023 · Dopamine agonists are used in patients with Parkinson disease. Dopamine agonists, such as ropinirole, are the first-line treatment for restless legs syndrome, while bromocriptine is given for neuroleptic malignant syndrome. Dopamine agonists are also prescribed to counteract dopamine antagonist-induced hyperprolactinemia.
- Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like ...
Dopamine agonists (DAs) have demonstrated efficacy for the...
- Side effects of a dopamine agonist therapy for Parkinson’s disease: a ...
Dopamine agonists (DA) are therapeutic agents that are...
- Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like ...
Dopamine agonists stimulate the parts of the brain influenced by dopamine. In effect, dopamine agonists trick the brain into thinking it is receiving the dopamine it needs. In general, dopamine agonists are not as potent as carbidopa-levodopa and may be less likely to cause dyskinesias.
6 Dis 2019 · Dopamine agonists are medications used to treat conditions like Parkinson's. They can be effective, but they may have significant side effects.
Current drug therapy in Parkinson's disease is symptomatic and primarily aimed at restoring dopaminergic function in the striatum.
7 Jul 2023 · Dopamine agonists (DAs) have demonstrated efficacy for the treatment of Parkinson’s disease (PD) but are limited by adverse effects (AEs). DAs can vary considerably in their receptor subtype selectivity and affinity, chemical composition, receptor occupancy, and intrinsic activity on the receptor.
27 Feb 2024 · The Role of Dopamine Agonists in Parkinson’s Treatment. What are dopamine receptor agonists? These medicines constitute a class of drugs used to treat Parkinson’s disease (PD) symptoms that mimic the action of naturally occurring dopamine.
24 Mac 2016 · Dopamine agonists (DA) are therapeutic agents that are commonly used in the treatment of Parkinson’s disease (PD). They can reduce undesired motor fluctuations and delay the administration of levodopa therapy. However, this drug family is associated with specific side effects that can significantly diminish the quality of life among PD patients.
